These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 22172011

  • 1. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
    Khuntawee W, Rungrotmongkol T, Hannongbua S.
    J Chem Inf Model; 2012 Jan 23; 52(1):76-83. PubMed ID: 22172011
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE, Hayes JM, Keramioti M, Mamais M, Oikonomakos NG, Kato A, Leonidas DD, Zographos SE.
    Food Chem Toxicol; 2013 Nov 23; 61():14-27. PubMed ID: 23279842
    [Abstract] [Full Text] [Related]

  • 4. Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
    Lu H, Chang DJ, Baratte B, Meijer L, Schulze-Gahmen U.
    J Med Chem; 2005 Feb 10; 48(3):737-43. PubMed ID: 15689157
    [Abstract] [Full Text] [Related]

  • 5. Structural basis for CDK6 activation by a virus-encoded cyclin.
    Schulze-Gahmen U, Kim SH.
    Nat Struct Biol; 2002 Mar 10; 9(3):177-81. PubMed ID: 11828325
    [Abstract] [Full Text] [Related]

  • 6. A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors.
    Sims PA, Wong CF, McCammon JA.
    J Med Chem; 2003 Jul 17; 46(15):3314-25. PubMed ID: 12852762
    [Abstract] [Full Text] [Related]

  • 7. Reducing CDK4/6-p16(INK4a) interface. Computational alanine scanning of a peptide bound to CDK6 protein.
    Villacañas O, Rubio-Martinez J.
    Proteins; 2006 Jun 01; 63(4):797-810. PubMed ID: 16508961
    [Abstract] [Full Text] [Related]

  • 8. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B, Milz S, Vogeser M, Michaelis C, Vorpahl M, Schömig A, Kastrati A, Wessely R.
    FASEB J; 2004 Aug 01; 18(11):1285-7. PubMed ID: 15180955
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition.
    Lu H, Schulze-Gahmen U.
    J Med Chem; 2006 Jun 29; 49(13):3826-31. PubMed ID: 16789739
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.
    Zaharevitz DW, Gussio R, Leost M, Senderowicz AM, Lahusen T, Kunick C, Meijer L, Sausville EA.
    Cancer Res; 1999 Jun 01; 59(11):2566-9. PubMed ID: 10363974
    [Abstract] [Full Text] [Related]

  • 15. GRID and docking analyses reveal a molecular basis for flavonoid inhibition of Src family kinase activity.
    Wright B, Watson KA, McGuffin LJ, Lovegrove JA, Gibbins JM.
    J Nutr Biochem; 2015 Nov 01; 26(11):1156-65. PubMed ID: 26140983
    [Abstract] [Full Text] [Related]

  • 16. The effect of the skeleton structure of flavanone and flavonoid on interaction with transferrin.
    Zhang XF, Han RM, Sun XR, Li GY, Yang QF, Li Q, Gai W, Zhang M, Chen L, Yang G, Tang YL.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6677-81. PubMed ID: 24239187
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 19. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F, Giuliano AE, Law RE, Van Herle AJ.
    Anticancer Res; 2001 Mar 15; 21(1A):413-20. PubMed ID: 11299771
    [Abstract] [Full Text] [Related]

  • 20. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
    Kaiser A, Nishi K, Gorin FA, Walsh DA, Bradbury EM, Schnier JB.
    Arch Biochem Biophys; 2001 Feb 15; 386(2):179-87. PubMed ID: 11368340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.